Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-28 @ 2:46 PM
Study NCT ID:
NCT05509933
Status:
RECRUITING
Last Update Posted:
2025-04-29
First Post:
2022-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
Sponsor:
Henry Ford Health System
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
15795
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None